Related references
Note: Only part of the references are listed.Prevalence of ANGPTL3 and APOB Gene Mutations in Subjects With Combined Hypolipidemia
Davide Noto et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2012)
LPL gene variants affect apoC-III response to combination therapy of statins and fenofibric acid in a randomized clinical trial of individuals with mixed dyslipidemia
Ariel Brautbar et al.
JOURNAL OF LIPID RESEARCH (2012)
Knowledge-Driven Analysis Identifies a Gene-Gene Interaction Affecting High-Density Lipoprotein Cholesterol Levels in Multi-Ethnic Populations
Li Ma et al.
PLOS GENETICS (2012)
Significance Levels in Genome-Wide Interaction Analysis (GWIA)
Tim Becker et al.
ANNALS OF HUMAN GENETICS (2011)
Variants in the APOA5 gene region and the response to combination therapy with statins and fenofibric acid in a randomized clinical trial of individuals with mixed dyslipidemia
Ariel Brautbar et al.
ATHEROSCLEROSIS (2011)
Genome-wide association analysis of total cholesterol and high-density lipoprotein cholesterol levels using the Framingham Heart Study data
Li Ma et al.
BMC MEDICAL GENETICS (2010)
Exome Sequencing, ANGPTL3 Mutations, and Familial Combined Hypolipidemia
Kiran Musunuru et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
The ACCORD Study Group. Effects of combination lipid therapy in type 2 diabetes mellitus.
Lukasz Januszkiewicz
KARDIOLOGIA POLSKA (2010)
Effects of Combination Lipid Therapy in Type 2 Diabetes Mellitus
Henry N. Ginsberg et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Efficacy and safety of ABT-335 (fenofibric acid) in combination with rosuvastatin in patients with mixed dyslipidemia: A phase 3 study
Peter H. Jones et al.
ATHEROSCLEROSIS (2009)
Genome-wide association analysis of metabolic traits in a birth cohort from a founder population
Chiara Sabatti et al.
NATURE GENETICS (2009)
Common variants at 30 loci contribute to polygenic dyslipidemia
Sekar Kathiresan et al.
NATURE GENETICS (2009)
Genetic Loci Associated With Plasma Concentration of Low-Density Lipoprotein Cholesterol, High-Density Lipoprotein Cholesterol, Triglycerides, Apolipoprotein A1, and Apolipoprotein B Among 6382 White Women in Genome-Wide Analysis With Replication
Daniel I. Chasman et al.
CIRCULATION-CARDIOVASCULAR GENETICS (2008)
Evaluation of a new formulation of fenofibric acid, ABT-335, co-administered with statins - Study design and rationale of a phase III clinical programme
Peter H. Jones et al.
CLINICAL DRUG INVESTIGATION (2008)
On multiple-testing correction in genome-wide association studies
Valentina Moskvina et al.
GENETIC EPIDEMIOLOGY (2008)
Polygenic determinants of severe hypertriglyceridemia
Jian Wang et al.
HUMAN MOLECULAR GENETICS (2008)
Association of cholesteryl ester transfer protein genotypes with CETP mass and activity, lipid levels, and coronary risk
Alexander Thompson et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2008)
Newly identified loci that influence lipid concentrations and risk of coronary artery disease
Cristen J. Willer et al.
NATURE GENETICS (2008)
Six new loci associated with blood low-density lipoprotein cholesterol, high-density lipoprotein cholesterol or triglycerides in humans
Sekar Kathiresan et al.
NATURE GENETICS (2008)
Common single-nucleotide polymorphisms act in concert to affect plasma levels of high-density lipoprotein cholesterol
Victor Spirin et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2007)
Fenofibrate effect on triglyceride and postprandial response of apolipoprotein A5 variants - The GOLDN study
Chao-Qiang Lai et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2007)
Differential regulation and properties of angiopoietin-like proteins 3 and 4
HF Ge et al.
JOURNAL OF LIPID RESEARCH (2005)
Peroxisome proliferator-activated receptor (PPAR)-α:: A pharmacological target with a promising future
DH van Raalte et al.
PHARMACEUTICAL RESEARCH (2004)
Angiopoietin-like protein 3 mediates hypertriglyceridemia induced by the liver X receptor
T Inaba et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Regulation of the angiopoietin-like protein 3 gene by LXR
R Kaplan et al.
JOURNAL OF LIPID RESEARCH (2003)
Epistasis: what it means, what it doesn't mean, and statistical methods to detect it in humans
HJ Cordell
HUMAN MOLECULAR GENETICS (2002)
Fibrate and statin synergistically increase the transcriptional activities of PPARα/RXRα and decrease the transactivation of NFκB
I Inoue et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2002)
PPAR-alpha and PPAR-gamma activators induce cholesterol removal from human macrophage foam cells through stimulation of the ABCA1 pathway
G Chinetti et al.
NATURE MEDICINE (2001)
Share Paper
